Literature DB >> 6529855

The plasma and erythrocyte fatty acid composition of poorly controlled, insulin-dependent (type I) diabetic patients and the effect of improved metabolic control.

J J van Doormaal, F A Muskiet, E van Ballegooie, W J Sluiter, H Doorenbos.   

Abstract

Analysis of the plasma and erythrocyte fatty acid composition of poorly controlled, insulin-dependent (type I) diabetic patients revealed a low level of 18:3c, omega 6, 20:3c, omega 6, 22:6c, omega 3 and total polyunsaturated fatty acids, and a high level of 18:0 and total saturated fatty acids. Improvement of diabetic control, achieved by treatment with continuous subcutaneous insulin infusion coincided with an increase of arachidonic acid and a normalization of total polyunsaturated fatty acids, with a concomitant decrease of total saturated fatty acids and total monounsaturated fatty acids, especially 18:1c, omega 9. The results of this study can be important for the dietary advice to poorly controlled, diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6529855     DOI: 10.1016/0009-8981(84)90055-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Effects of short-term high dose intake of evening primrose oil on plasma and cellular fatty acid compositions, alpha-tocopherol levels, and erythropoiesis in normal and type 1 (insulin-dependent) diabetic men.

Authors:  J J van Doormaal; I G Idema; F A Muskiet; I A Martini; H Doorenbos
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

2.  Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes.

Authors:  Y Min; K Ghebremeskel; C Lowy; B Thomas; M A Crawford
Journal:  Diabetologia       Date:  2003-11-22       Impact factor: 10.122

3.  Association of Polymorphism in Fatty Acid Desaturase Gene with the Risk of Type 2 Diabetes in Iranian Population.

Authors:  Vahid Mansouri; Shaghayegh Haghjooy Javanmard; Manijeh Mahdavi; Mohammad Hasan Tajedini
Journal:  Adv Biomed Res       Date:  2018-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.